Nutritional approach is mostly indicated in case of nephropathy and gastrointestinal symptoms.
2
Diabetic nephropathy is a common, complex disease with a clear genetic predisposition.
3
However, the effect of isoliquiritigenin on diabetic nephropathy has never been explored.
4
Patients with BKVAN exhibited a higher viral replication than patients without nephropathy.
5
Diabetic nephropathy and nephroangiosclerosis were the main causes of end-stage renal disease.
1
Rates were unchanged for influenza and pneumonia and nephritis, nephrotic syndrome and nephrosis.
2
The patient remained in remission until 1 year after levamisole withdrawal, when clinical nephrosis recurred.
3
Immunohistochemical staining and Western blotting were used to localize heparanase protein in normal kidneys and kidneys from rats with PAN nephrosis.
4
These results show that additional microtubules are present around the Golgi apparatus during the enhanced production of plasma proteins which occurs in nephrosis.
1
The Centers for Medicare and Medicaid Services has made some exceptions in very few cases, such as for end-stage renaldisorder patients.
2
The rationale for the use of the reciprocal creatinine plot to detect a progressive renaldisorder superimposed upon a preexisting progressive renaldisorder, is discussed.
3
Further, traditional healers frequently use the title plant to mitigate of renaldisorders.
4
Chronic inflammation is a major outcome determinant in several renaldisorders.
5
Objective: Protein restriction delays the progression of non-diabetic and type 1 diabetic renaldisorders.
Uso de kidney disease em inglês
1
Introduction: Chronic kidneydisease is now regarded as amajor public health concern.
2
Evidence for risk factors to identify patients with kidneydisease is limited.
3
Context: Hyperuricemia is an independent risk factor for progression of kidneydisease.
4
Patients: 1628 patients with chronic kidneydisease participating in the MDRD Study.
5
Summary: Transplant recipients are a unique group of chronic kidneydisease patients.
6
Aging-associated kidneydisease is usually considered a degenerative process associated with aging.
7
The drugs are also used to treat anemia in kidneydisease patients.
8
The trial enrolled 121 patients with moderate to severe chronic kidneydisease.
9
If levels are high, the patient is likely to have kidneydisease.
10
The number of eGFR measurements to detect kidneydisease can be reduced.
11
These factors increase inflammation, oxidative stress, and progression of chronic kidneydisease.
12
Amgen also markets another ESA drug called Epogen for kidneydisease patients.
13
Improvements in care of individuals with kidneydisease could reduce these costs.
14
Oxidative stress is acknowledged to play a role in kidneydisease progression.
15
The polycystic kidneydisease is a hereditary malformation seldom described in Africa.
16
Aranesp is approved to treat anemia associated with chemotherapy and kidneydisease.